The pathological involvement of amyloid precursor protein (APP) in Alzheimer’s disease (AD) has been widely documented in the last 30 years due to its involvement in the generation of β-amyloid (Aβ) peptide [1]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.